Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard M Breyer

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
Expression and molecular pharmacology of the mouse CRTH2 receptorAaron N Hata, Roy Zent, Matthew D Breyer, et al.
Molecular Pharmacology|November 26, 2004
Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2Aaron N Hata, Terry P Lybrand, Lawrence J Marnett, et al.
Brain Pathology (Zurich, Switzerland)|May 26, 2005
Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neuronsFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
Glia|May 28, 2005
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunityFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
Prostaglandins & Other Lipid Mediators|May 16, 2002
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivoXiaodong Li, Masato Tomita, Carol C Pilbeam, et al.
Glia|February 15, 2011
Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activationXianwu Li, Eiron Cudaback, C Dirk Keene, et al.
Cancer Research|June 3, 2005
The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasiaSung-Hee Chang, Youxi Ai, Richard M Breyer, et al.
Vascular Pharmacology|June 5, 2016
Regulation of arterial reactivity by concurrent signaling through the E-prostanoid receptor 3 and angiotensin receptor 1Maria P Kraemer, Hyehun Choi, Jeff Reese, et al.
Neuroscience Letters|May 13, 2008
Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemiaJun Li, Xibin Liang, Qian Wang, et al.
Molecular Pharmacology|October 23, 2012
Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptorChandramohan Natarajan, Aaron N Hata, Heidi E Hamm, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
Expression and molecular pharmacology of the mouse CRTH2 receptorAaron N Hata, Roy Zent, Matthew D Breyer, et al.
Molecular Pharmacology|November 26, 2004
Structural determinants of arylacetic acid nonsteroidal anti-inflammatory drugs necessary for binding and activation of the prostaglandin D2 receptor CRTH2Aaron N Hata, Terry P Lybrand, Lawrence J Marnett, et al.
Brain Pathology (Zurich, Switzerland)|May 26, 2005
Microglial EP2 as a new target to increase amyloid beta phagocytosis and decrease amyloid beta-induced damage to neuronsFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
Glia|May 28, 2005
Microglial EP2 is critical to neurotoxicity from activated cerebral innate immunityFeng-Shiun Shie, Kathleen S Montine, Richard M Breyer, et al.
Prostaglandins & Other Lipid Mediators|May 16, 2002
Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivoXiaodong Li, Masato Tomita, Carol C Pilbeam, et al.
Glia|February 15, 2011
Suppressed microglial E prostanoid receptor 1 signaling selectively reduces tumor necrosis factor alpha and interleukin 6 secretion from toll-like receptor 3 activationXianwu Li, Eiron Cudaback, C Dirk Keene, et al.
Cancer Research|June 3, 2005
The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasiaSung-Hee Chang, Youxi Ai, Richard M Breyer, et al.
Vascular Pharmacology|June 5, 2016
Regulation of arterial reactivity by concurrent signaling through the E-prostanoid receptor 3 and angiotensin receptor 1Maria P Kraemer, Hyehun Choi, Jeff Reese, et al.
Neuroscience Letters|May 13, 2008
Misoprostol, an anti-ulcer agent and PGE2 receptor agonist, protects against cerebral ischemiaJun Li, Xibin Liang, Qian Wang, et al.
Molecular Pharmacology|October 23, 2012
Extracellular loop II modulates GTP sensitivity of the prostaglandin EP3 receptorChandramohan Natarajan, Aaron N Hata, Heidi E Hamm, et al.
Pageof 9